Literature DB >> 21684113

Tissue doppler imaging and plasma BNP levels to assess the prognosis in patients with hypertrophic cardiomyopathy.

Hiroaki Kitaoka1, Toru Kubo, Makoto Okawa, Nana Takenaka, Chiyo Sakamoto, Yuichi Baba, Kayo Hayashi, Naohito Yamasaki, Yoshihisa Matsumura, Yoshinori L Doi.   

Abstract

BACKGROUND: In addition to sudden death, heart failure and stroke due to atrial fibrillation are important in patients with hypertrophic cardiomyopathy (HCM). The aim of the present study was to determine whether Doppler tissue imaging findings and plasma B-type natriuretic peptide (BNP) levels, which are widely used for risk stratification in several cardiovascular diseases, are useful for risk stratification in patients with HCM in a regional cohort.
METHODS: One hundred thirty patients (82 men; mean age, 60 ± 16 years) with HCM were enrolled in this study.
RESULTS: Twenty end points were observed during a mean follow-up period of 3.7 ± 1.7 years. Septal E/e' ratios and BNP levels in patients with events were higher than those in patients without events (17.4 ± 6.3 vs 10.6 ± 4.3, P < .0001, and 441 ± 304 vs 202 ± 174 pg/mL, P < .0001, respectively). By multivariate logistic regression analysis, a high septal E/e' ratio, in addition to a history of syncope and documentation of atrial fibrillation, was a significant predictor of combined end points. In contrast, plasma BNP levels were not a significant predictor of combined end points.
CONCLUSION: Assessment by Doppler tissue imaging is useful for further risk stratification of patients with HCM.
Copyright © 2011 American Society of Echocardiography. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21684113     DOI: 10.1016/j.echo.2011.05.009

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  13 in total

Review 1.  Clinical Relevance of the Spectral Tissue Doppler E/e' Ratio in the Management of Patients with Atrial Fibrillation: a Comprehensive Review of the Literature.

Authors:  Stephane Arques
Journal:  J Atr Fibrillation       Date:  2018-08-31

Review 2.  Apical variant hypertrophic cardiomyopathy "multimodality imaging evaluation".

Authors:  Gary Huang; Shaimaa A Fadl; Stan Sukhotski; Manuela Matesan
Journal:  Int J Cardiovasc Imaging       Date:  2019-12-18       Impact factor: 2.357

Review 3.  [Hypertrophic and restrictive cardiomyopathy. Differentiation by imaging].

Authors:  S Fritschi; M Prothmann; J Schulz-Menger
Journal:  Herz       Date:  2015-06       Impact factor: 1.443

4.  Upregulation of rat P23 (a member of the YjgF protein family) by fasting, glucose diet and fatty acid feeding.

Authors:  F Levy-Favatier; A Leroux; B Antoine; B Nedelec; M Delpech
Journal:  Cell Mol Life Sci       Date:  2004-11       Impact factor: 9.261

Review 5.  Contemporary Diagnosis and Management of Hypertrophic Cardiomyopathy: The Role of Echocardiography and Multimodality Imaging.

Authors:  Takeshi Kitai; Andrew Xanthopoulos; Shoko Nakagawa; Natsuko Ishii; Masashi Amano; Filippos Triposkiadis; Chisato Izumi
Journal:  J Cardiovasc Dev Dis       Date:  2022-05-25

6.  The association between brain natriuretic peptide and tissue Doppler parameters in children with hypertrophic cardiomyopathy.

Authors:  Taliha Öner; Rahmi Özdemir; Filiz Hazan; Cem Karadeniz; Önder Doksoz; Murat Muhtar Yilmazer; Timur Meşe; Vedide Tavli
Journal:  Bosn J Basic Med Sci       Date:  2016-01-01       Impact factor: 3.363

Review 7.  Biomarkers in cardiology--part 1--in heart failure and specific cardiomyopathies.

Authors: 
Journal:  Arq Bras Cardiol       Date:  2014-11-28       Impact factor: 2.000

8.  Left ventricular filling pressure assessed by exercise TDI was correlated with early HFNEF in patients with non-obstructive hypertrophic cardiomyopathy.

Authors:  Guodong Ma; Ming Xu; Wei Gao; Zhaoping Li; Weihong Li; Baoxia Chen; Jieli Feng; Hongyan Wang; Wenying Ma; Hui Chen; Aidong Shen; Xinheng Feng; Yongzhen Zhang
Journal:  BMC Cardiovasc Disord       Date:  2014-12-18       Impact factor: 2.298

9.  Doppler myocardial performance index combined with plasma B-type natriuretic peptide levels as a marker of cardiac function in patients with decompensated cirrhosis.

Authors:  Li-Kun Wang; Xiao-Fei An; Xue-Liang Wu; Su-Mei Zhang; Rui-Min Yang; Chao Han; Jie-Lin Yang; Yi-Cheng Wang
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

10.  Association between genetic variants in the HIF1A-VEGF pathway and left ventricular regional myocardial deformation in patients with hypertrophic cardiomyopathy.

Authors:  Guido E Pieles; Jaime Alkon; Cedric Manlhiot; Chun-Po Steve Fan; Caroline Kinnear; Leland N Benson; Seema Mital; Mark K Friedberg
Journal:  Pediatr Res       Date:  2020-05-06       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.